Establishment of a Multi‐Stage In Vitro Screening Platform to Identify Candidate Compounds for Intestinal Mucosal Damage in Inflammatory Bowel Disease
Mucosal healing is a key therapeutic goal in inflammatory bowel disease (IBD), which is characterized by mucosal lesions in the gastrointestinal tract. For IBD drug development, it is important to identify multiple compounds with strong effects on mucosal injury and different mechanisms of action. Here, we established an intestinal organoid-based assay to evaluate cytokine-induced inflammatory and epithelial stress responses. We also developed an intestinal microphysiological system (intestinal MPS)-based assay for quantitative evaluation of cytokine-induced changes in mucosal architecture. By integrating these assays, we constructed a multi-stage screening platform to identify candidate compounds that suppress inflammatory responses and preserve mucosal architecture. Tofacitinib, an approved IBD drug, showed positive effects in these assays, supporting the relevance of this platform. Although organoid-based screening identified pimitespib as a candidate compound, pimitespib did not improve mucosal architecture in the intestinal MPS. Consistently, pimitespib failed to restore mucosal morphology in an IBD mouse model. These findings suggest that combining intestinal organoids with an intestinal MPS may help identify candidate compounds that suppress inflammatory responses while preserving mucosal architecture.
Authors
- Rina Hashimoto (ORCID: https://orcid.org/0000-0002-7174-4563)
- Hiromitsu Fuse
- Kazuo Takayama (ORCID: https://orcid.org/0000-0002-1132-2457)
- Ryosuke Negoro (ORCID: https://orcid.org/0000-0002-6567-575X)
- Sayaka Deguchi (ORCID: https://orcid.org/0009-0007-2392-554X)
- Kaori Kosugi
- Fuki Yokoi
- Akira Ohta (ORCID: https://orcid.org/0009-0008-1500-6911)
- Takuya Yamamoto
Institutions
- Kyoto University (JP)
- Nozaki Tokushukai Hospital (JP)
- Center for iPS Cell Research and Application, Kyoto University (JP)
- Institute for the Advanced Study of Human Biology, Kyoto University (JP)
- Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo (JP)
- The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- Advanced Healthcare Materials
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1002/adhm.71984
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Ministry of Education, Culture, Sports, Science and Technology
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency